कृपया अन्य खोज का प्रयास करें
Oxford Cannabinoid Technologies Holdings Plc, a pharmaceutical company, engages in the research, development, and commercialization of cannabinoid-based prescription medicines. Its lead drug candidate consists of OCT461201, an CB2 receptor, that is in phase – I clinical trial for use in the treatment of chemotherapy-induced peripheral neuropathy and irritable bowel syndrome (IBS), as well as in neuropathic and visceral pain conditions. The company is also developing OCT130401, which is in pre-clinical development for the treatment of trigeminal neuralgia. In addition, its development pipeline includes cannabinoid derivative products comprising OCT960609, a dual CB1 and CB2 agonist targeting an undisclosed neuropathic pain indications; and immunotherapy agents for the treatment of solid tumours. Oxford Cannabinoid Technologies Holdings Plc was incorporated in 2017 and is headquartered in London, the United Kingdom.
नाम | आयु | पहले | शीर्षक |
---|---|---|---|
Julie Patricia Pomeroy | 67 | 2021 | Independent Non-Executive Chair |
Indraneil Mahapatra | 43 | 2021 | Co-Founder & Non-Executive Director |
Clarissa Ann Sowemimo-Coker | 42 | 2018 | CEO & Executive Director |
Paul William Smalley | 50 | 2022 | Finance Director & Executive Director |
Charanjit Dhillon | 64 | 2021 | Senior Independent Non-Executive Director |
Timothy H. Corn | 72 | 2023 | Executive Director & Chief Medical Officer |
Anthony Dickenson | - | 2022 | Member of Scientific Advisory Board |
. Mott | - | 2024 | Independent Non-Executive Director |
Robert H. Dworkin | - | 2022 | Member of Scientific Advisory Board |
Giorgio Lambru | - | 2022 | Member of Scientific Advisory Board |
William Paul Farquhar-Smith | - | - | Member of Scientific Advisory Board |
क्या आप सच में %USER_NAME% को ब्लॉक करना चाहते हैं?
ऐसा करके, आप और %USER_NAME% नहीं देख पाएंगे किसी अन्य के Investing.com की पोस्ट में से कोई भी।
%USER_NAME% को सफलतापूर्वक आपकी ब्लॉक सूची में जोड़ लिया गया है
क्योंकि आपने इस व्यक्ति को अनब्लॉक कर दिया है, आपको ब्लॉक को रिन्यू करने से पहले 48 घंटे प्रतीक्षा करनी होगी।
मुझे लगता है कि यह टिपण्णी:
धन्यवाद!
आपकी रिपोर्ट समीक्षा के लिए हमारे मॉडरेटर को भेजी गई है